Establishment and characterization of multidrug-resistant human osteosarcoma cell lines

M. Serra, K. Scotland, M. C. Manara, D. Maurici, P. L. Lollini, C. De Giovanni, G. Toffoli, N. Baldini

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Multidrug resistant variants of two human osteosarcoma cell lines (U-2 OS and Saos-2) were selected by continuous exposure to doxorubicin. The in vitro and in vivo growth characteristics of these sublines as well as the expression of osteoblastic markers and of some surface antigens were analyzed. Resistant variants showed a higher doubling time and a lower cloning efficiency, and a lower metastatic ability after i.v. injection than corresponding parental cell lines. All the sublines showed overexpression of p-glycoprotein (referred to as pl70). The level of expression of this protein in the different cell lines was directly related to the degree of resistance as shown by the in vitro sensitivity to doxorubicin and other multidrug-related drugs. In sublines showing the highest levels of resistance (over 300-fold), pl70 overexpression was associated with mdr 1 gene amplification. These are the first multidrug resistant human osteosarcoma cell lines ever reported. They may be used as a model for further investigations into the mechanisms of drug resistance in osteosarcoma and as a standard for the assessment of chemosensitivity in clinical samples.

Original languageEnglish
Pages (from-to)323-329
Number of pages7
JournalAnticancer Research
Volume13
Issue number2
Publication statusPublished - 1993

Fingerprint

Osteosarcoma
Cell Line
Doxorubicin
Gene Amplification
Surface Antigens
Drug Resistance
Organism Cloning
Glycoproteins
Injections
Growth
Pharmaceutical Preparations
Proteins
In Vitro Techniques

Keywords

  • Doxorubicin
  • Multidrug resistance
  • Osteosarcoma
  • P-glycoprotein

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Establishment and characterization of multidrug-resistant human osteosarcoma cell lines. / Serra, M.; Scotland, K.; Manara, M. C.; Maurici, D.; Lollini, P. L.; De Giovanni, C.; Toffoli, G.; Baldini, N.

In: Anticancer Research, Vol. 13, No. 2, 1993, p. 323-329.

Research output: Contribution to journalArticle

Serra, M. ; Scotland, K. ; Manara, M. C. ; Maurici, D. ; Lollini, P. L. ; De Giovanni, C. ; Toffoli, G. ; Baldini, N. / Establishment and characterization of multidrug-resistant human osteosarcoma cell lines. In: Anticancer Research. 1993 ; Vol. 13, No. 2. pp. 323-329.
@article{8c332c6a17b240b798e8ca3af4cfafc2,
title = "Establishment and characterization of multidrug-resistant human osteosarcoma cell lines",
abstract = "Multidrug resistant variants of two human osteosarcoma cell lines (U-2 OS and Saos-2) were selected by continuous exposure to doxorubicin. The in vitro and in vivo growth characteristics of these sublines as well as the expression of osteoblastic markers and of some surface antigens were analyzed. Resistant variants showed a higher doubling time and a lower cloning efficiency, and a lower metastatic ability after i.v. injection than corresponding parental cell lines. All the sublines showed overexpression of p-glycoprotein (referred to as pl70). The level of expression of this protein in the different cell lines was directly related to the degree of resistance as shown by the in vitro sensitivity to doxorubicin and other multidrug-related drugs. In sublines showing the highest levels of resistance (over 300-fold), pl70 overexpression was associated with mdr 1 gene amplification. These are the first multidrug resistant human osteosarcoma cell lines ever reported. They may be used as a model for further investigations into the mechanisms of drug resistance in osteosarcoma and as a standard for the assessment of chemosensitivity in clinical samples.",
keywords = "Doxorubicin, Multidrug resistance, Osteosarcoma, P-glycoprotein",
author = "M. Serra and K. Scotland and Manara, {M. C.} and D. Maurici and Lollini, {P. L.} and {De Giovanni}, C. and G. Toffoli and N. Baldini",
year = "1993",
language = "English",
volume = "13",
pages = "323--329",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Establishment and characterization of multidrug-resistant human osteosarcoma cell lines

AU - Serra, M.

AU - Scotland, K.

AU - Manara, M. C.

AU - Maurici, D.

AU - Lollini, P. L.

AU - De Giovanni, C.

AU - Toffoli, G.

AU - Baldini, N.

PY - 1993

Y1 - 1993

N2 - Multidrug resistant variants of two human osteosarcoma cell lines (U-2 OS and Saos-2) were selected by continuous exposure to doxorubicin. The in vitro and in vivo growth characteristics of these sublines as well as the expression of osteoblastic markers and of some surface antigens were analyzed. Resistant variants showed a higher doubling time and a lower cloning efficiency, and a lower metastatic ability after i.v. injection than corresponding parental cell lines. All the sublines showed overexpression of p-glycoprotein (referred to as pl70). The level of expression of this protein in the different cell lines was directly related to the degree of resistance as shown by the in vitro sensitivity to doxorubicin and other multidrug-related drugs. In sublines showing the highest levels of resistance (over 300-fold), pl70 overexpression was associated with mdr 1 gene amplification. These are the first multidrug resistant human osteosarcoma cell lines ever reported. They may be used as a model for further investigations into the mechanisms of drug resistance in osteosarcoma and as a standard for the assessment of chemosensitivity in clinical samples.

AB - Multidrug resistant variants of two human osteosarcoma cell lines (U-2 OS and Saos-2) were selected by continuous exposure to doxorubicin. The in vitro and in vivo growth characteristics of these sublines as well as the expression of osteoblastic markers and of some surface antigens were analyzed. Resistant variants showed a higher doubling time and a lower cloning efficiency, and a lower metastatic ability after i.v. injection than corresponding parental cell lines. All the sublines showed overexpression of p-glycoprotein (referred to as pl70). The level of expression of this protein in the different cell lines was directly related to the degree of resistance as shown by the in vitro sensitivity to doxorubicin and other multidrug-related drugs. In sublines showing the highest levels of resistance (over 300-fold), pl70 overexpression was associated with mdr 1 gene amplification. These are the first multidrug resistant human osteosarcoma cell lines ever reported. They may be used as a model for further investigations into the mechanisms of drug resistance in osteosarcoma and as a standard for the assessment of chemosensitivity in clinical samples.

KW - Doxorubicin

KW - Multidrug resistance

KW - Osteosarcoma

KW - P-glycoprotein

UR - http://www.scopus.com/inward/record.url?scp=0027285463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027285463&partnerID=8YFLogxK

M3 - Article

C2 - 8100126

AN - SCOPUS:0027285463

VL - 13

SP - 323

EP - 329

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2

ER -